1. Home
  2. GMED vs TECH Comparison

GMED vs TECH Comparison

Compare GMED & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • TECH
  • Stock Information
  • Founded
  • GMED 2003
  • TECH 1976
  • Country
  • GMED United States
  • TECH United States
  • Employees
  • GMED N/A
  • TECH N/A
  • Industry
  • GMED Medical/Dental Instruments
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GMED Health Care
  • TECH Health Care
  • Exchange
  • GMED Nasdaq
  • TECH Nasdaq
  • Market Cap
  • GMED 7.2B
  • TECH 8.3B
  • IPO Year
  • GMED 2012
  • TECH 1989
  • Fundamental
  • Price
  • GMED $60.61
  • TECH $54.41
  • Analyst Decision
  • GMED Buy
  • TECH Buy
  • Analyst Count
  • GMED 13
  • TECH 12
  • Target Price
  • GMED $87.30
  • TECH $70.91
  • AVG Volume (30 Days)
  • GMED 1.3M
  • TECH 1.9M
  • Earning Date
  • GMED 11-04-2025
  • TECH 10-29-2025
  • Dividend Yield
  • GMED N/A
  • TECH 0.59%
  • EPS Growth
  • GMED 745.36
  • TECH N/A
  • EPS
  • GMED 2.57
  • TECH 0.46
  • Revenue
  • GMED $2,626,461,000.00
  • TECH $1,219,635,000.00
  • Revenue This Year
  • GMED $15.55
  • TECH $4.13
  • Revenue Next Year
  • GMED $7.97
  • TECH $7.56
  • P/E Ratio
  • GMED $23.43
  • TECH $118.15
  • Revenue Growth
  • GMED 17.43
  • TECH 5.23
  • 52 Week Low
  • GMED $51.79
  • TECH $46.01
  • 52 Week High
  • GMED $94.93
  • TECH $80.95
  • Technical
  • Relative Strength Index (RSI)
  • GMED 54.65
  • TECH 51.07
  • Support Level
  • GMED $58.25
  • TECH $51.62
  • Resistance Level
  • GMED $61.61
  • TECH $57.60
  • Average True Range (ATR)
  • GMED 1.26
  • TECH 1.65
  • MACD
  • GMED -0.23
  • TECH -0.20
  • Stochastic Oscillator
  • GMED 53.03
  • TECH 46.66

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: